Related Experiment Video
Updated: Sep 20, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.1K
Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis
Takashi Yamaguchi1, Katsunori Yoshida1, Miki Murata1
1Department of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan.
International Journal of Molecular Sciences
|June 10, 2022
Summary
Nonalcoholic fatty liver disease (NAFLD) can progress to liver cancer. Transforming growth factor-beta (TGF-β) signaling, specifically Smad3 phosphorylation, plays a key role in this process, offering potential biomarkers for hepatocellular carcinoma (HCC) in NASH patients.
Area of Science:
- Hepatology
- Molecular Biology
- Cancer Research
Background:
- Nonalcoholic fatty liver disease (NAFLD) involves hepatic steatosis, insulin resistance, and oxidative stress, potentially progressing to nonalcoholic steatohepatitis (NASH), fibrosis, and end-stage liver disease.
- Hepatic fibrosis and carcinogenesis often share inflammatory pathways, but NASH can directly cause liver cancer via insulin resistance, oxidative stress, and lipotoxicity, bypassing significant inflammation or fibrosis.
- Transforming growth factor-beta (TGF-β) signaling is crucial in both hepatic fibrogenesis and carcinogenesis.
Purpose of the Study:
- To review the role of TGF-β/Smad signaling in hepatic carcinogenesis associated with NASH.
- To explore the differential phosphorylation of Smad3 and its impact on hepatocyte proliferation and carcinogenesis.
- To discuss the potential of Smad phospho-isoforms as predictive biomarkers for hepatocellular carcinoma (HCC) in NASH patients.
Main Methods:
- Review of existing literature on TGF-β/Smad signaling pathways in liver disease.
- Analysis of the mechanisms by which Smad3 phosphorylation (pSmad3C and pSmad3L) influences cell proliferation and carcinogenesis.
- Investigation into the role of Ras/JNK activation in modulating Smad3 signaling.
Main Results:
- TGF-β type I receptor (TβRI) and Ras/JNK signaling differentially phosphorylate Smad3 into pSmad3C and pSmad3L isoforms.
- TβRI/pSmad3C signaling inhibits cell proliferation, while constitutive Ras activation and JNK-mediated pSmad3L promote hepatocyte proliferation and carcinogenesis.
- The pSmad3L pathway antagonizes the cytostatic effects of pSmad3C signaling, contributing to liver cancer development.
Conclusions:
- TGF-β/Smad signaling is a critical mediator in NASH-related hepatic carcinogenesis.
- Differential Smad3 phosphorylation (pSmad3C vs. pSmad3L) dictates cell proliferation and cancer progression.
- Smad phospho-isoforms may serve as valuable biomarkers for predicting HCC risk in patients with NASH, irrespective of cirrhosis status.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
03:14Notch Signaling Pathway
4.5K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K